Nooshin Hashemi

Nooshin Hashemi is an accomplished medical professional with extensive experience in oncology, currently serving as the Executive Medical Director for Oncology Late Development at Gilead Sciences since June 2025. Previously, Nooshin held the position of Executive Medical Director for Oncology Early Development at Astellas Pharma from November 2022 to June 2025, and prior roles at Amgen included Early Clinical Development Lead and Medical Director in Hematology/Oncology. Nooshin's academic career includes various faculty positions at the University of Cincinnati Cancer Institute and the Cleveland Clinic Foundation, where significant contributions to medicine were made from 2011 to 2018. Educational qualifications include an MD from Tehran University of Medical Sciences, along with advanced training and coursework at multiple esteemed institutions, including the Cleveland Clinic Foundation and the State University of New York.